Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure
about
Update on Advances in Research on Idiosyncratic Drug-Induced Liver InjuryXenobiotic and Endobiotic Mediated Interactions Between the Cytochrome P450 System and the Inflammatory Response in the LiverNew genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivityIsoniazid metabolism and hepatotoxicityMechanism of isoniazid‐induced hepatotoxicity: then and nowDrug-induced liver injury: recent advances in diagnosis and risk assessment.Pharmacogenetics of isoniazid-induced hepatotoxicity.The pregnane X receptor in tuberculosis therapeutics.Dexamethasone Pretreatment Alleviates Isoniazid/Lipopolysaccharide Hepatotoxicity: Inhibition of Inflammatory and Oxidative Stress.Role of CYP3A in isoniazid metabolism in vivoDrug-induced liver injury: what was new in 2013?Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis.CYP2E1 autoantibodies in liver diseasesHepatotoxicity mechanisms of isoniazid: A mini-review.The chemical, genetic and immunological basis of idiosyncratic drug-induced liver injury.Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury.PharmGKB summary: isoniazid pathway, pharmacokinetics.Isoniazid hepatotoxicity: progress in understanding the immunologic component.Inhibition of immune tolerance unmasks drug-induced allergic hepatitis.Deficiency of N-acetyltransferase increases the interactions of isoniazid with endobiotics in mouse liver.Histopathological challenges in suspected drug-induced liver injury.Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy.Deleterious effects of 28-day oral co-administration of first-line anti-TB drugs on spleen, blood and bone marrow chromosomes in normal rat.Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset.From the Cover: Characterization of Isoniazid-Specific T-Cell Clones in Patients with anti-Tuberculosis Drug-Related Liver and Skin Injury.Drug-specific CD4+ T-cell immune responses are responsible for antituberculosis drug-induced maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms syndrome.The effect of ageing on isoniazid pharmacokinetics and hepatotoxicity in Fischer 344 rats.
P2860
Q26779078-6C303BAD-6E02-455D-AA6A-B1ECE64C84CCQ26800213-B53CB69D-07B6-46D2-B7A1-36C072BCC9BDQ26800976-F2C6965E-7522-4635-8A93-C3B14709DB4FQ28076859-CC402252-2D66-4481-869C-CD0A9830D125Q29248263-16F1DF3C-C39C-4B22-B2C6-B6CB0FB0068CQ30235089-BDD730A9-9572-4E7D-963B-7F22EA3E57E2Q35669887-35A9E627-C6C4-41E2-B626-2841150EC3DFQ36451492-958F6157-1CCC-4107-846C-14C30CE37CD4Q37699610-C656BEBA-EBD9-4EA0-B5BE-E67037268D0CQ37732312-A8C25E4E-043F-44D0-A5E4-FD97B5819679Q38205591-4C0FED5C-2047-4274-81E2-2EC88593E5A5Q38271339-FDD77F6B-DA72-48E5-B1B8-A45792A2B1BBQ38280871-AC800714-16EC-44E0-B795-F8609C5DA4F1Q38533596-9537C3C6-48B5-4CA5-B09F-F456CA22A1DAQ38651282-340F2118-EE60-4DE8-935F-22480EE9FE19Q39366146-FEAC076A-2093-4078-BC42-75E86E91878CQ42090708-FC881FC2-9B2B-45D9-B617-2B365B0BAE0AQ42775512-349CC790-21D5-445A-B51D-1E505A2E5BFBQ43505002-971D3291-EC6C-4703-BA09-2207B5A57439Q47828041-6D36D16A-414A-4D69-96E3-58E539541ACDQ48136372-6BA07628-E523-48C6-B9EB-4B05022E64C5Q48296572-A46D3378-8FC5-402E-B756-321E57DAF227Q50892160-5595F0E3-627B-4682-8EE3-3E50785F1866Q51126002-A13726A5-7DEE-4DA2-B749-D4ED7A00D948Q51427499-D4B8627C-2F74-49B3-8C2C-F10FFDCAF919Q53151986-F86AC3C0-8056-42CE-A0C3-7C18EC388673Q55022756-9E111098-5822-4D1D-9D5C-9D687E00C650
P2860
Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Detection of anti-isoniazid an ...... soniazid-induced liver failure
@en
Detection of anti-isoniazid an ...... oniazid-induced liver failure.
@nl
type
label
Detection of anti-isoniazid an ...... soniazid-induced liver failure
@en
Detection of anti-isoniazid an ...... oniazid-induced liver failure.
@nl
prefLabel
Detection of anti-isoniazid an ...... soniazid-induced liver failure
@en
Detection of anti-isoniazid an ...... oniazid-induced liver failure.
@nl
P2093
P2860
P356
P1433
P1476
Detection of anti-isoniazid an ...... soniazid-induced liver failure
@en
P2093
Acute Liver Study Group
Corron Sanders
Imir G Metushi
Jack Uetrecht
William M Lee
P2860
P304
P356
10.1002/HEP.26564
P407
P577
2014-01-27T00:00:00Z